In vitro synergistic activity of colistin with aminoglycosides, beta-lactams and rifampin against multidrug-resistant gram-negative bacteria

被引：5
作者：
Chitnis, S.
Chitnis, V.
Chitnis, D. S. [1 ]
机构：
[1] Choithram Hosp & Res Ctr, Dept Microbiol & Immunol, Indore 452014, Madhya Pradesh, India
[2] Shri Aurobindo Inst Med Sci, Dept Microbiol, Indore, Madhya Pradesh, India
来源：
JOURNAL OF CHEMOTHERAPY | 2007年 / 19卷 / 02期
关键词：
D O I：
10.1179/joc.2007.19.2.226
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：226 / 229
页数：4
相关论文
共 11 条
  • [1] [Anonymous], 2002, M100S12 NCCLS
  • [2] Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
    Falagas, ME
    Bliziotis, IA
    Kasiakou, SK
    Samonis, G
    Athanassopoulou, P
    Michalopoulos, A
    [J]. BMC INFECTIOUS DISEASES, 2005, 5 (1)
  • [3] Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines
    Gales, AC
    Reis, AO
    Jones, RN
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) : 183 - 190
  • [4] In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa
    Giamarellos-Bourboulis, EJ
    Sambatakou, H
    Galani, I
    Giamarellou, H
    [J]. JOURNAL OF CHEMOTHERAPY, 2003, 15 (03) : 235 - 238
  • [5] Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model
    Gunderson, BW
    Ibrahim, KH
    Hovde, LB
    Fromm, TL
    Reed, MD
    Rotschafer, JC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) : 905 - 909
  • [6] Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
    Levin, AS
    Barone, AA
    Penço, J
    Santos, MV
    Marinho, IS
    Arruda, EAG
    Manrique, EI
    Costa, SF
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) : 1008 - 1011
  • [7] Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa
    Linden, PK
    Kusne, S
    Coley, K
    Fontes, P
    Kramer, DJ
    Paterson, D
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (11) : E154 - E160
  • [8] LORIAN V, 1991, PROCEDURE THEORETICA, P1
  • [9] LORIAN VB, 1980, COMBINATION ANTIBIOT, P305
  • [10] Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
    Markou, N
    Apostolakos, H
    Koumoudiou, C
    Athanasiou, M
    Koutsoukou, A
    Alamanos, I
    Gregorakos, L
    [J]. CRITICAL CARE, 2003, 7 (05): : R78 - R83
12